DRI Capital is a Toronto, Ontario-based private equity firm that buys the royalty streams of pharmaceutical and biotechnology products from life-science companies. DRI prefers to purchase items that have already won government approval, and because the investments are long-term in nature, the strength of the underlying intellectual property is critical.
Venture Capital
FIRST CANADIAN PLACE, 100 KING ST. WEST
SUITE 7250, POB 62
TORONTO, ONTARIO, M5X 1B1
Canada
7 funds found in our dataset.
Built for investment teams that need to move faster.
Intelligently process data room financials, generate auditable analyses, and export IC-ready deliverables.